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Historically, Kaposi’s sarcoma (KS) has been rare in the United
Kingdom, both in relation to other neoplasms, and in international
terms (Grulich et al, 1992). However, its profile has become more
prominent since it was first reported among homosexual men in
the United States (Centers for Disease Control, 1981) at the
beginning of the global AIDS epidemic.
The spread of HIV and AIDS in Scotland has been documented
in detail elsewhere (Goldberg et al, 1996, 1998). In summary, HIV
first entered populations of homosexual/bisexual males and
injecting drug users not later than 1982 and 1983, respectively
(Goldberg et al, 1996). The majority of homosexual/bisexual
males have been over 30 years old at the time of diagnosis and
their progression to AIDS is likely to have been more rapid than
the generally younger cohort of injecting drug users. Epidemic
spread of HIV among injecting drug users occurred during
1983–86, particularly in Edinburgh and Dundee (Goldberg et al,
1996). By the end of 1997, a cumulative total of 2725 persons in
Scotland had been identified as HIV antibody-positive (Goldberg
et al, 1998). Just under half of cases were in injecting drug users,
one third in homosexual/bisexual males, and one seventh were
men or women in whom infection was attributed to heterosexual
intercourse; 76% of all infected cases were male.
The purpose of the present study is to describe the secular trends
in incidence of KS in Scotland before and during the AIDS
epidemic, to describe geographical variations in incidence in
recent years, and to examine the survival of persons with KS.
MATERIALS AND METHODS
On the basis of the International Classification of Diseases for
Oncology (WHO, 1976) morphology code M-9140/3, incident
cases of KS for the years 1976–96 were identified and extracted
from the Scottish Cancer Registry (SCR). This registry covers the
whole of Scotland (population approximately 5.1 million); data
quality is believed to be high, in terms of both accuracy and
completeness (Harris et al, 1998). The registry collects a range of
patient- and tumour-related information, including demographic
and diagnostic details. Every year, mortality data, supplied by the
General Register Office (Scotland), are linked to cancer registra-
tion records by computerized probability matching (Black et al,
1993).
Mid-year population estimates were derived from the Annual
Reports of the Registrar General for Scotland (Registrar General
for Scotland, 1977–97). Age-standardized rates were calculated
by direct standardization to the World Standard Population
(Waterhouse et al, 1976). Within Scotland, the incidence of KS in
each health board area of residence was compared to the incidence
in Scotland as a whole by indirect standardization to produce
standardized incidence ratios (SIR); exact 95% confidence
intervals for the SIRs were calculated (Breslow and Day, 1987).
Cumulative observed survival was estimated using the
Kaplan–Meier method (Kaplan and Meier, 1958).
For comparison, annual numbers of cases of AIDS-defining KS
by sex, transmission category and year of diagnosis, covering the
period 1986–96 were obtained from the Scottish Centre for
Infection and Environmental Health (SCIEH). Scotland’s AIDS
case-reporting scheme involves consultant clinicians registering
patients diagnosed as having AIDS, with SCIEH. An HIV-infected
person is defined as having AIDS if he/she has any single
opportunistic infection or cancer within an epidemiologically
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accepted range of such conditions. Information on KS held by
SCIEH relates only to cases in which KS was an indicator disease
at the time of notification, and does not include subsequent
diagnoses of KS.
RESULTS
In total, 96 cases of KS (82 males) were registered with an inci-
dence date falling within the 21-year period of study (1976–96).
Table 1 shows, for all cases (SCR data), and for cases known to be
AIDS-defining (SCIEH data), the annual number of cases by sex
and year of diagnosis. Of the 45 AIDS-defining cases (SCIEH
data), the HIV transmission category was recorded as male homo-
sexual intercourse in 42 cases, and sexual intercourse between
men and women in the remaining three cases.
Hereafter, the results relate to all cases of KS (SCR data).
Secular trends in age-standardized incidence rates by sex are
shown in Figure 1. In males, the incidence rate remained below
0.09 per 100 000 person years at risk during the period 1976–85.
The incidence rate then rose steeply, eventually peaking at 0.44 in
1991. Thereafter, incidence declined quite steeply but only to
around the rate seen in 1987. In females, the incidence rate
remained below 0.06 per 100 000 person years at risk during the
whole study period, with no substantial change over time.
Figure 2 shows, for males, changes in age-specific incidence
curves for three consecutive 7-year periods of diagnosis (1976–82,
1983–89 and 1990–96). Primarily, this demonstrates a marked
shift in age distribution towards younger ages at diagnosis. No
such pattern is evident for females (Figure 3).
Within Scotland, for males aged under 50 years during the
period 1986–96 the highest incidence was seen in the Lothian
Health Board area (which includes the city of Edinburgh) with a
standardized incidence ratio (SIR) of 380 (95% confidence inter-
vals 265, 528).
For all patients diagnosed during the period 1976–92, the cum-
ulative observed survival at 5 years was 8.7% for the age group
0–49 years and 49.8% for the age group 50–84 years.
Table 1 Kaposi’s sarcoma in Scotland, 1976–96: annual number of cases by sex and year of diagnosis for all KS (SCRa data)
and for AIDS-defining KS (SCIEHb data)
Annual number of cases
Year of diagnosis All KS (SCR data) AIDS-defining KS (SCIEH data)c
Males Females Both sexes Males Females Both sexes
1976 2–2–––
1977 –33–––
1978 1–1–––
1979 ––––––
1980 ––––––
1981 1–1–––
1982 –11–––
1983 –11–––
1984 112–––
1985 112–––
1986 3144–4
1987 5–53–3
1988 4–42–2
1989 2–2415
1990 13 – 137–7
1991 13 1 149–9
1992 8 2 102–2
1993 10 – 104–4
1994 617516
1995 6172–2
1996 6171–1
Total 82 14 96 43 2 45
aScottish Cancer Registry. bScottish Centre for Infection and Environmental Health. cDoes not include KS arising in individuals after
notification of their AIDS diagnoses to SCIEH.1940 DH Brewster et al
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Figure 1 Kaposi’s sarcoma (ICD-O M-9140/3) in Scotland, 1976–96: age-standardized incidence rates (World standard population) by sex and year of
diagnosis
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DISCUSSION
As expected, the total number of cases of KS (SCR data) exceeds
the number reported to be AIDS-defining (SCIEH data). The
apparent excess of AIDS-defining cases in 1989 is likely to reflect
different definitions of, or misclassification of, incidence date
between the two databases.
Compared to background incidence during the decade 1976–85
(13 cases), the incidence during the subsequent 11 years (83 cases)
is higher than can be accounted for by AIDS-defining KS reported
to SCIEH (45 cases). However, it is important to remember that
SCIEH do not hold data on cases of AIDS-related KS diagnosed
after initial notification with a different AIDS indicator disease,
such as Pneumocystis carinii pneumonia. Other possible explana-
tions for the discrepancy include: under-ascertainment by SCR
during the earlier period of observation, leading to under-estima-
tion of the background incidence; registration of some invalid
cases by SCR during the more recent period; or a genuine, recent
parallel increase in the incidence of classic KS.
The concentration of AIDS-defining KS among individuals who
probably acquired HIV through anal sexual intercourse is certainly
not a new finding. Historically, AIDS-defining KS has been more
common in Britain among homosexual men whose likely source
of infection included contacts from the United States or Africa,
implying the existence of a sexually transmissible agent or other
co-factor distinct from HIV which plays an important part in the
aetiology of AIDS-related KS (Beral et al, 1991). This agent is
now thought to be Kaposi’s-sarcoma-associated Herpesvirus
(human Herpesvirus 8), and it has been identified in both HIV-
positive and HIV-negative patients (Moore and Chang, 1998).
In a country in which the transmission of HIV has been more
common among injecting drug users than male homosexuals, one
might not expect a dramatic change in the epidemiology of KS
with the advent of AIDS. Nevertheless, the impact of AIDS is
clearly discernible in males, both in terms of the increase in age-
standardized incidence rates from the mid-1980s onwards, and in
terms of the shift in age distribution over time. Despite the impact
of AIDS, however, KS remains rare in Scotland, both in the
context of other neoplasms, and in international terms. For
example, in Scotland for the period 1986–95, 46 944 new cases of
lung cancer were registered (Harris et al, 1998) compared with
only 76 cases of KS; and, during the period 1988–92, the age-
standardized incidence rate of KS in males was 33.5 per 100 000
in ‘non-Hispanic whites’ from San Francisco compared with 0.3 in
Scotland (Parkin et al, 1997).
The fall in incidence among males in Scotland since the early
1990s may reflect the observation that, as a proportion of AIDS-
defining illnesses, KS has been reported to have decreased from
1987–89 to 1993–94 in homosexual and bisexual men in all
European regions and in the United States (Franceschi et al, 1997).
In Scotland, the number of AIDS cases diagnosed rose from 345 to
480 between the periods 1982–91 and 1992–96, but the number in
which KS was reported to be an indicator disease fell from 27
(7.8%) to 13 (2.7%) (Allardice et al, 1996), despite a similar
number of male homosexuals being diagnosed with AIDS in each
period (165 and 172 cases, respectively). This trend may be partly
due to the shorter latency period between acquisition of HIV infec-
tion and development of KS than is seen between acquisition of
HIV and onset of other AIDS-defining illnesses (Hermans et al,
1996). Equally, it might reflect the adoption of safer sexual
practices among homosexual men (Dore et al, 1996). The latter
hypothesis is supported by falling numbers of new cases of
gonococcal infection in men in Scotland from the mid-1980s to a
trough in 1994 (Scottish Centre for Infection and Environmental
Health, 1998), although recent data suggest that unprotected anal
intercourse is still occurring and may be becoming more common
again among homosexual men (Young et al, 1997). While the
advent of intensive antiretroviral therapies may also now be
contributing to the decline in KS incidence (Michaels et al, 1998),
it is probably too recent to account for the decline which began in
the early 1990s.
The fact that the highest rate of KS in males under 50 years
during the period 1986–96 was recorded in Lothian Health Board
area is consistent with two observations. First, it reflects the fact
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that 45% of all known HIV-infected individuals in Scotland have
been reported to be in this area (Goldberg et al, 1998), despite
the fact that it contains only approximately 15% of the Scottish
population (Registrar General for Scotland, 1997). Second, it is
consistent with the fact that Lothian has high rates of rectal gono-
coccal infection in men compared with Scotland as a whole
(Young et al, 1997).
Risk of KS is also increased in organ transplant recipients
receiving immunosuppressive therapy (Kinlen, 1982). While the
population of organ transplant recipients at risk in Scotland is
certainly increasing over time (Junor, 1996; Walker, 1996), the
absence of any discernible rise in incidence of KS among females
suggests that immunosuppressive therapy following organ trans-
plantation has not played a major part in shaping trends in KS in
Scotland.
In contrast to virtually all other neoplasms (Black et al, 1993),
survival has been worse in younger than in older age groups in
recent years. This reflects the more aggressive nature of AIDS-
related KS, as well as the other co-morbidities and competing
causes of death which are associated with AIDS. Certainly, median
survival for AIDS patients presenting with KS has been consis-
tently reported as between only 19 and 22 months (Allardice et al,
1996).
In conclusion, although the HIV epidemic has had a demon-
strable impact on the epidemiology of KS in males in Scotland, KS
remains rare in the context of the total burden of cancer in
Scotland, and compared with its reported incidence in many other
countries.
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